ES2978309T3 - Métodos para purificar anticuerpos - Google Patents

Métodos para purificar anticuerpos Download PDF

Info

Publication number
ES2978309T3
ES2978309T3 ES19198005T ES19198005T ES2978309T3 ES 2978309 T3 ES2978309 T3 ES 2978309T3 ES 19198005 T ES19198005 T ES 19198005T ES 19198005 T ES19198005 T ES 19198005T ES 2978309 T3 ES2978309 T3 ES 2978309T3
Authority
ES
Spain
Prior art keywords
protein
acid
antibody
superantigen
tris
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES19198005T
Other languages
English (en)
Spanish (es)
Inventor
Kent E Goklen
Eric J Suda
Antonio Raul Ubiera
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Intellectual Property Development Ltd
Original Assignee
GlaxoSmithKline Intellectual Property Development Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50391244&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2978309(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by GlaxoSmithKline Intellectual Property Development Ltd filed Critical GlaxoSmithKline Intellectual Property Development Ltd
Application granted granted Critical
Publication of ES2978309T3 publication Critical patent/ES2978309T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/22Affinity chromatography or related techniques based upon selective absorption processes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
    • B01D15/3804Affinity chromatography
    • B01D15/3809Affinity chromatography of the antigen-antibody type, e.g. protein A, G or L chromatography
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065Purification, fragmentation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/569Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ES19198005T 2013-03-15 2014-03-13 Métodos para purificar anticuerpos Active ES2978309T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361787309P 2013-03-15 2013-03-15

Publications (1)

Publication Number Publication Date
ES2978309T3 true ES2978309T3 (es) 2024-09-10

Family

ID=50391244

Family Applications (2)

Application Number Title Priority Date Filing Date
ES19198005T Active ES2978309T3 (es) 2013-03-15 2014-03-13 Métodos para purificar anticuerpos
ES14713926T Active ES2765206T3 (es) 2013-03-15 2014-03-13 Procedimientos de purificación de anticuerpos

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES14713926T Active ES2765206T3 (es) 2013-03-15 2014-03-13 Procedimientos de purificación de anticuerpos

Country Status (15)

Country Link
US (3) US10676503B2 (enExample)
EP (3) EP3680000B1 (enExample)
JP (2) JP6599773B2 (enExample)
KR (1) KR102114021B1 (enExample)
CN (1) CN105188872B (enExample)
AU (1) AU2014229280B2 (enExample)
BR (1) BR112015022321A2 (enExample)
CA (1) CA2902287A1 (enExample)
DK (2) DK3680000T3 (enExample)
ES (2) ES2978309T3 (enExample)
IL (1) IL240753B (enExample)
RU (1) RU2651483C2 (enExample)
SG (1) SG11201506494XA (enExample)
TW (1) TWI625335B (enExample)
WO (1) WO2014141150A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3680000B1 (en) 2013-03-15 2024-03-13 GlaxoSmithKline Intellectual Property Development Limited Methods for purifying antibodies
CA2910065C (en) 2013-05-15 2023-09-19 Medimmune Limited Purification of recombinantly produced polypeptides
EP3842108A1 (en) 2014-04-30 2021-06-30 Novo Nordisk A/S Methods for the purification of proteins using caprylic acid
JP6663360B2 (ja) 2015-01-26 2020-03-11 株式会社カネカ 変異型免疫グロブリンκ鎖可変領域結合性ペプチド
WO2016121701A1 (ja) 2015-01-26 2016-08-04 株式会社カネカ 免疫グロブリンκ鎖可変領域含有タンパク質精製用アフィニティー分離マトリックス
WO2017195638A1 (ja) * 2016-05-09 2017-11-16 株式会社カネカ 抗体またはκ鎖可変領域含有抗体断片の精製方法
EP4389757A3 (en) * 2016-09-07 2025-01-01 GlaxoSmithKline Intellectual Property Development Limited Methods for purifying antibodies
CN106939045B (zh) * 2017-05-01 2020-03-31 深圳市国创纳米抗体技术有限公司 一种单克隆抗体细胞培养液澄清的方法
CN108085358A (zh) * 2018-02-08 2018-05-29 保定冀中药业有限公司 一种犬细小病毒单克隆抗体IgG2b-Fab片段的制备方法
TW202003555A (zh) 2018-03-07 2020-01-16 英商葛蘭素史克智慧財產發展有限公司 用於純化重組多肽之方法
TW202000891A (zh) 2018-03-07 2020-01-01 英商葛蘭素史克智慧財產發展有限公司 純化抗體之方法
JP2023539163A (ja) * 2020-08-18 2023-09-13 ザルトリウス ビーアイエー セパレーションズ ディー.オー.オー. 宿主細胞dnaの金属アフィニティー抽出
CN114133446A (zh) * 2021-12-31 2022-03-04 方坦思(上海)生物医药有限公司 单克隆抗体的纯化方法
CN116179582A (zh) * 2022-09-27 2023-05-30 南京医事达生物科技有限公司 一种通用型基因重组蛋白质a亲和纯化填料制备方法和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57106673A (en) 1980-12-24 1982-07-02 Chugai Pharmaceut Co Ltd Dibenzo(b,f)(1,4)oxazepin derivative
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US5429746A (en) * 1994-02-22 1995-07-04 Smith Kline Beecham Corporation Antibody purification
US6955917B2 (en) 1997-06-20 2005-10-18 Bayer Healthcare Llc Chromatographic method for high yield purification and viral inactivation of antibodies
IL127127A0 (en) 1998-11-18 1999-09-22 Peptor Ltd Small functional units of antibody heavy chain variable regions
DK2272378T3 (da) * 2001-06-01 2014-10-06 Upfront Chromatography As Fraktionering af proteinholdige blandinger
DK1419179T3 (da) 2001-08-10 2010-06-21 Univ Aberdeen Antigenbindingsdomæner fra fisk
WO2003102208A2 (en) 2002-05-31 2003-12-11 Indian Council Of Agricultural Research Rapid detection of bt-cry toxins
PT1718675E (pt) * 2004-02-27 2013-05-21 Octapharma Ag Método de proporcionar uma preparação purificada de anticorpos livre de vírus
JP2008500972A (ja) * 2004-05-14 2008-01-17 キリンファーマ株式会社 免疫グロブリンの精製方法
US8263750B2 (en) * 2006-03-16 2012-09-11 Amgen Inc. Method for purifying a protein using protein-A affinity chromatography using an intermediate wash step
AU2007292253A1 (en) 2006-09-08 2008-03-13 Wyeth Arginine wash in protein purification using affinity chromatography
US20080167450A1 (en) * 2007-01-05 2008-07-10 Hai Pan Methods of purifying proteins
WO2012135415A1 (en) 2011-03-29 2012-10-04 Glaxosmithkline Llc Buffer system for protein purification
EP3680000B1 (en) 2013-03-15 2024-03-13 GlaxoSmithKline Intellectual Property Development Limited Methods for purifying antibodies
CA2910065C (en) * 2013-05-15 2023-09-19 Medimmune Limited Purification of recombinantly produced polypeptides
IL244149B2 (en) 2013-09-13 2025-09-01 Genentech Inc Methods and compositions containing purified recombinant polypeptides

Also Published As

Publication number Publication date
WO2014141150A1 (en) 2014-09-18
CN105188872A (zh) 2015-12-23
RU2015136860A (ru) 2017-04-28
EP2969098A1 (en) 2016-01-20
IL240753B (en) 2021-01-31
EP4371996A3 (en) 2024-08-14
IL240753A0 (en) 2015-10-29
TW201522365A (zh) 2015-06-16
JP2020019795A (ja) 2020-02-06
US10676503B2 (en) 2020-06-09
EP3680000B1 (en) 2024-03-13
JP7002511B2 (ja) 2022-02-21
CA2902287A1 (en) 2014-09-18
AU2014229280A1 (en) 2015-10-01
JP6599773B2 (ja) 2019-10-30
US20200277330A1 (en) 2020-09-03
CN105188872B (zh) 2019-01-15
ES2765206T3 (es) 2020-06-08
RU2651483C2 (ru) 2018-04-19
SG11201506494XA (en) 2015-09-29
KR102114021B1 (ko) 2020-05-22
EP2969098B1 (en) 2019-10-30
TWI625335B (zh) 2018-06-01
DK2969098T3 (da) 2020-01-27
EP3680000A1 (en) 2020-07-15
US20160024146A1 (en) 2016-01-28
US12358945B2 (en) 2025-07-15
AU2014229280B2 (en) 2017-01-05
KR20150131235A (ko) 2015-11-24
BR112015022321A2 (pt) 2017-07-18
US20250353878A1 (en) 2025-11-20
EP4371996A2 (en) 2024-05-22
JP2016519052A (ja) 2016-06-30
DK3680000T3 (da) 2024-04-02

Similar Documents

Publication Publication Date Title
ES2978309T3 (es) Métodos para purificar anticuerpos
ES2979153T3 (es) Métodos para purificar anticuerpos
ES2784628T3 (es) Sistema de tampón para purificación de proteína
EP3762411A1 (en) Methods for purifying recombinant polypeptides